Literature DB >> 17985794

Vision-related quality of life comparison for emmetropes, myopes after refractive surgery, and myopes wearing spectacles or contact lenses.

Christine Y Chen1, Jill E Keeffe, Pam Garoufalis, Fakir M A Islam, Mohamed Dirani, Terry A Couper, Hugh R Taylor, Paul N Baird.   

Abstract

PURPOSE: To compare the vision-related quality of life among emmetropes, myopes who had refractive surgery, and myopes who wore spectacles and/or contact lenses.
METHODS: This cross-sectional study assessed vision-related quality of life using the Vision Quality of Life Index. Participants were age 18 years or older with a presenting visual acuity of 20/40 or better and no other ocular pathology. Responses were compared among three groups: emmetropes (spherical equivalent [SE] < 0.50 to > -0.50 diopters [D]), myopes (SE < or = -0.50 D) who wore spectacles and/or contact lenses, and myopes who had refractive surgery.
RESULTS: The study population included 64 emmetropes, 66 myopes who wore spectacles and/or contact lenses, and 65 myopes who had refractive surgery. No significant differences were found between the refractive surgery and emmetropic groups. In contrast, the spectacle and/or contact lens group had significantly increased odds of having concerns about injuring themselves (odds ratio = 11.5, 95% confidence interval [CI] 2.3, 57.1), difficulties coping with demands in life (odds ratio = 23.6, 95% CI 23.8, 198.1), difficulties fulfilling roles (odds ratio = 5.6, 95% CI 1.4, 22.1), and less confidence joining in everyday activities (odds ratio = 30.6, 95% CI 3.2, 292.3) compared to emmetropes.
CONCLUSIONS: Myopia corrected with spectacles or contact lenses had a negative impact on some areas of vision-related quality of life. However, individuals with myopia who had refractive surgery enjoyed the same vision-related quality of life as those with emmetropia. The potential improvement in vision-related quality of life should be considered when recommending treatment for myopia.

Entities:  

Mesh:

Year:  2007        PMID: 17985794     DOI: 10.3928/1081-597X-20071001-04

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  7 in total

1.  Wavefront-guided laser in situ keratomileusis (Lasik) versus wavefront-guided photorefractive keratectomy (Prk): a prospective randomized eye-to-eye comparison (an American Ophthalmological Society thesis).

Authors:  Edward E Manche; Weldon W Haw
Journal:  Trans Am Ophthalmol Soc       Date:  2011-12

Review 2.  Stereopsis after corneal refractive surgeries: a systematic review and meta-analysis.

Authors:  Alireza Peyman; Mohsen Pourazizi; Mohamadreza Akhlaghi; Awat Feizi; Alireza Rahimi; Elham Soltani
Journal:  Int Ophthalmol       Date:  2022-01-18       Impact factor: 2.029

3.  Comparison of quality of life between myopic patients with spectacles and contact lenses, and patients who have undergone refractive surgery.

Authors:  Nastaran Shams; Hossein Mobaraki; Mohammad Kamali; Ebrahim Jafarzadehpour
Journal:  J Curr Ophthalmol       Date:  2015-11-17

4.  Visual outcomes and quality of life before and after photorefractive keratectomy.

Authors:  Kholoud Ahmad Bokhary; Elham Saeed Alshamrani; Rania Fahmy
Journal:  Indian J Ophthalmol       Date:  2022-01       Impact factor: 1.848

5.  Vision Related Quality of Life in Myopia; Photorefractive Keratectomy versus Nonsurgical Optical Correction.

Authors:  Hossein Ziaei; Marzieh Katibeh; Maryam Sabbaghi; Mehdi Yaseri; Armen Eskandari
Journal:  J Ophthalmic Vis Res       Date:  2012-07

6.  Hepatocyte growth factor and myopia: genetic association analyses in a Caucasian population.

Authors:  Tammy Yanovitch; Yi-Ju Li; Ravikanth Metlapally; Diana Abbott; Khanh-Nhat Tran Viet; Terri L Young
Journal:  Mol Vis       Date:  2009-05-20       Impact factor: 2.367

7.  The impact of spectacle wear compliance on the visual function related quality of life of Omani students: A historical cohort study.

Authors:  Rajiv B Khandekar; Urmi P Gogri; Saleh Al Harby
Journal:  Oman J Ophthalmol       Date:  2013-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.